📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. (2021)

First Author: McCarthy C

Attributed to: MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05373-8

PubMed Identifier: 34225765

Publication URI: http://europepmc.org/abstract/MED/34225765

Type: Journal Article/Review

Volume: 22

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215